News - Partners
MMV remains committed to defeating malaria
Dundee and MMV make rapid progress towards a potential new treatment for malaria
EU-funded report recommends
Anacor Pharmaceuticals and MMV extend development agreement for AN3661.
Prof. Stephen Ward and his team are awarded The Royal Society for Chemistry’s prestigious Malcolm Campbell Memorial Award.
New MMV-sponsored antimalarial receives approval from the Korean FDA.
Academic brain and industrial muscle came together to make DHODH an award winning drug discovery project.
The three year research agreement aims to develop drug candidates from a set of sanofi-aventis’ compounds.
AN3661 will undergo preclinical studies with the hope of developing a new and effective next generation antimalarial.
The stimulus for this project follows reports of the emergence of artemisinin resistance on the Thai-Cambodian border.
